Marsh (FRA:MSN) Research & Development: €0 Mil (TTM As of Mar. 2026)


FRA:MSN Marsh FRA:MSN
78 GF Score
Price €143.35
GF Value €217.53
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Marsh Research & Development?

Marsh FRA:MSN +4.18% 78 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates FRA:MSN with a GF Score™ of 78/100 and a GF Value™ of €217.53 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Marsh's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Marsh  (FRA:MSN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Marsh Research & Development Related Terms

Marsh Research & Development Historical Data

* Premium members only.

The historical data trend for Marsh's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marsh Research & Development Chart

Marsh Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Marsh Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:MSN
78GF Score
Marsh FRA:MSN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marsh Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Marsh (FRA:MSN) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Marsh and its competitors.
Is Marsh's Research & Development too high?
Marsh's current Research & Development is €0 Mil. Overall, Marsh has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Marsh's Research & Development compare to AON and AJG?
Marsh's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Marsh and its competitors. Marsh's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marsh stock overvalued right now?
Based on GuruFocus' analysis, Marsh (FRA:MSN) is currently considered Significantly Undervalued. The stock's GF Value™ is €217.53, compared to a current price of €143.35 — trading 34.1% below its estimated fair value. The current Research & Development is €0 Mil. Marsh's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Marsh (FRA:MSN), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Marsh (FRA:MSN) Overvalued in 2026?

Based on GuruFocus' analysis, Marsh stock appears to be undervalued. The current stock price of €143.35 is trading 34.1% below its estimated GF Value™ of €217.53. GuruFocus considers Marsh to be Significantly Undervalued.

Key valuation signals for FRA:MSN:

  • Research & Development: €0 Mil
  • GF Value™: €217.53 vs. price of €143.35 (34.1% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the FRA:MSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Marsh Business Description

Address 1166 Avenue of the Americas, New York, NY, USA, 10036-2774
Marsh is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
78GF Score

Get the complete analysis for FRA:MSN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.35
Price
€217.53
GF Value